![Zac Germon Profile](https://pbs.twimg.com/profile_images/1816617280857604100/oEpbjHIM_x96.jpg)
Zac Germon
@ZacGermon
Followers
114
Following
333
Statuses
63
Post Doctoral Scientist @ University of Newcastle | Cell Signalling | Proteomics | Leukaemia + DIPG | CSRG #DunLab
Joined September 2019
@MattDun17 @charles_debock @NatureComms @KidsCancerInst I have! Amazing data, congrats to all involved.
0
0
1
Thanks Heather, looking forward to it!
On July 18, I'll be hosting @XuDongZhang15 and @ZacGermon at an online seminar for @AEpiA. I'm looking forward to showcasing the work of two great colleagues from @UON_research and @HMRIAustralia . Tune in for some fabulous science and discussion!
0
0
7
Thanks @CancerAustralia & @KidsCancerProj! Excited to be given the opportunity to continue this project investigating much needed novel treatment strategies for Paediatric cancers #AML #DMG #DIPG
Delighted #DunLab 's childhood cancer project was funded by @CancerAustralia & @KidsCancerProj Free-radicals (#ROS) promote cancer signaling in RTK mutant- #AML & #DMG #DIPG Here we will develop new targeted treatments Congrats @ZacGermon @duchatel_ryan @Jonatha16752881 DE & ID
1
2
10
RT @MattDun17: Wonderful to see the glossy version & cover of #DunLab’s latest paper discovering the genetic dependency & targeting of PI3K…
0
14
0
Congratulations @MattDun17! So well deserved. Your dedication and determination inspire us each day in the fight against kids cancer!
So thankful to receive this prestigious award on behalf of our incredible #DunLab team May I thank all our #CSRG team & recognise the inspirational scientists that did all the work particularly @evierjackson @duchatel_ryan @AliciaD0uglas @DilanaStaudt @ZacGermon #DIPG 💪 @RUNDIPG
0
0
7
Congrats, Sam and team! A super interesting review. Thank you for the opportunity to contribute.
Our new review on #hypoxia and #DNAmethylation in #AML is online today. We explored complex and bi-directional interactions between hypoxia signalling and regulation of DNA methylation as well as implications for AML therapy.
0
0
5
@Bryce_Thomas23 @DilanaStaudt @MattDun17 @VitanzaNick @michelle_monje Congrats Bryce and team, on a great paper and an awesome image!
0
0
2
@MattDun17 @PrecisionMedUON @UON_research Thanks Matt, and thank you for all the support and opportunities you have given me along the way. To be continued!
0
0
6
Congrats Evie and team! Great summary of this paper below.
Incredibly proud to share the latest work from #DunLab, published in #CancerResearch! We highlight the combination of ONC201 and paxalisib for the treatment of DMG, the preclinical data informing PNOC022. Follow this tweetorial for a summary: (1/10)
0
0
6
RT @scisignal: A new study shows that inhibiting the oxidase NOX2 suppresses a common subtype of #AcuteMyeloidLeukemia (AML) in mice by blo…
0
4
0
RT @MattDun17: Probably my favourite part of adding to the literature, students/stuff pinning their first author papers to our walls of hon…
0
6
0
Excited to see this paper published today in @scisignal. This work formed a large part of my PhD and is summarised below:
#DunLab paper alert: Patients diagnosed with the most common driver mutation in acute myeloid leukemia (AML) – FLT3, are associated with poor-outcomes. FLT3+ AML sees the overproduction of reactive oxygen species (ROS), a second messenger signaling (T1)
5
5
18
RT @MattDun17: Access to new drugs in paediatric oncology: can we learn from the ongoing ONC201 saga? @TheLancetOncol #DunLab, #CSRG @UO…
0
15
0